SomaLogic Q2 EPS $(0.13) Beats $(0.16) Estimate, Sales $20.47M Beat $19.82M Estimate
Portfolio Pulse from Benzinga Newsdesk
SomaLogic (NASDAQ:SLGC) reported Q2 earnings per share of $(0.13), beating the analyst consensus estimate of $(0.16) by 18.75%. The company's quarterly sales were $20.47 million, surpassing the analyst consensus estimate of $19.82 million by 3.27%. This represents a 44.71% increase over the same period last year.
August 14, 2023 | 8:07 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
SomaLogic's Q2 earnings and sales beat analyst estimates, which could positively impact the stock in the short term.
SomaLogic's better-than-expected Q2 earnings and sales could lead to increased investor confidence, potentially driving the stock price up in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100